Suzhou Historical Income Statement
| 301258 Stock | 22.92 0.07 0.30% |
Historical analysis of Suzhou Fushilai income statement accounts such as Net Interest Income of 4.6 M, Interest Income of 5.1 M or Interest Expense of 242.3 K can show how well Suzhou Fushilai Pharmaceutical performed in making a profits. Evaluating Suzhou Fushilai income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Suzhou Fushilai's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Suzhou Fushilai Phar latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Suzhou Fushilai Phar is a good buy for the upcoming year.
Suzhou |
About Suzhou Income Statement Analysis
Suzhou Fushilai Phar Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Suzhou Fushilai shareholders. The income statement also shows Suzhou investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Suzhou Fushilai Income Statement Chart
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Total Revenue
Total revenue comprises all receipts Suzhou Fushilai Phar generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Suzhou Fushilai Pharmaceutical minus its cost of goods sold. It is profit before Suzhou Fushilai operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Suzhou Fushilai's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Suzhou Fushilai Phar current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Suzhou Fushilai Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Suzhou Fushilai's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 242.3 K, whereas Net Interest Income is forecasted to decline to about 4.6 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Net Interest Income | 6.3M | 7.8M | 7.0M | 4.6M | Tax Provision | 25.2M | 16.4M | 14.7M | 17.3M |
Suzhou Fushilai income statement Correlations
Click cells to compare fundamentals
Suzhou Fushilai Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Suzhou Fushilai income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 23.8M | 18.2M | 25.2M | 16.4M | 14.7M | 17.3M | |
| Net Interest Income | 1.4M | 1.3M | 6.3M | 7.8M | 7.0M | 4.6M | |
| Interest Income | 1.6M | 2.0M | 6.7M | 8.1M | 7.3M | 5.1M | |
| Selling General Administrative | 19.3M | 16.2M | 22.2M | 20.0M | 18.0M | 18.8M | |
| Total Revenue | 476.8M | 521.7M | 568.2M | 489.3M | 562.7M | 551.9M | |
| Gross Profit | 225.4M | 210.2M | 257.0M | 187.9M | 169.1M | 177.0M | |
| Operating Income | 167.9M | 144.7M | 171.3M | 96.2M | 86.6M | 119.7M | |
| Net Income From Continuing Ops | 141.1M | 120.2M | 177.3M | 112.2M | 101.0M | 111.4M | |
| Research Development | 22.9M | 28.5M | 41.4M | 40.7M | 46.8M | 33.4M | |
| Cost Of Revenue | 251.5M | 311.5M | 311.2M | 301.4M | 346.6M | 308.5M | |
| Total Operating Expenses | 309.0M | 377.0M | 396.9M | 393.1M | 452.0M | 387.3M | |
| Reconciled Depreciation | 33.6M | 46.1M | 51.9M | 56.6M | 65.1M | 41.6M | |
| Income Before Tax | 164.8M | 138.4M | 202.5M | 128.5M | 115.7M | 128.7M | |
| Net Income | 141.1M | 120.2M | 177.3M | 112.2M | 101.0M | 111.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Suzhou Stock
Suzhou Fushilai Phar Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Suzhou Fushilai shareholders. The income statement also shows Suzhou investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).